Kodiak Sciences Inc. (KOD) awards CFO 66,500 stock options
Rhea-AI Filing Summary
Kodiak Sciences Inc. reported a compensation grant to Chief Financial Officer John A. Borgeson of stock options covering 66,500 shares of common stock on July 15, 2026. The options have an exercise price of $42.42 per share, expire on July 14, 2036, and were fully unvested at grant. One-forty-eighth of the shares vest one month after July 1, 2026, with the remaining shares vesting in forty-seven equal monthly installments thereafter, subject to his Continuous Service under the 2018 Equity Incentive Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
BORGESON JOHN A.
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 66,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 66,500 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 66,500 shares
Exercise price: $42.42 per share
Expiration date: July 14, 2036
+2 more
5 metrics
Stock options granted
66,500 shares
Grant to CFO John A. Borgeson on July 15, 2026
Exercise price
$42.42 per share
Exercise price of stock option grant
Expiration date
July 14, 2036
Option term end date for the grant
Underlying shares
66,500 shares
Common stock underlying the reported options
Post-transaction derivative holdings
66,500 options
Total derivative securities held after the reported acquisition
Key Terms
Stock Option (Right to Buy), Continuous Service, 2018 Equity Incentive Plan, vesting
4 terms
Stock Option (Right to Buy) financial
"Reported as "Stock Option (Right to Buy)" in the transaction details"
Continuous Service financial
"Subject to the Reporting Person's Continuous Service as of each vesting date"
2018 Equity Incentive Plan financial
"Continuous Service (as defined in the 2018 Equity Incentive Plan)"
vesting financial
"Shares vest in a series of forty-seven successive equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Kodiak Sciences (KOD) report for CFO John A. Borgeson?
Kodiak Sciences reported that CFO John A. Borgeson received a grant of 66,500 stock options on July 15, 2026. These options are compensation-based, carry a $42.42 exercise price, and relate to shares of Kodiak Sciences common stock, vesting over four years.
What is the exercise price of the new Kodiak Sciences (KOD) stock options granted to the CFO?
The stock options granted to Kodiak Sciences CFO John A. Borgeson have an exercise price of $42.42 per share. This means he can purchase Kodiak common shares at $42.42 once the options vest, subject to the grant’s vesting and service conditions.
What is the vesting schedule for Kodiak Sciences (KOD) CFO John A. Borgeson’s new options?
The options vest over 48 monthly installments: 1/48 vests one month after July 1, 2026, and the remaining shares vest in 47 equal monthly installments. Vesting requires the CFO’s Continuous Service under the 2018 Equity Incentive Plan.
When do Kodiak Sciences (KOD) CFO John A. Borgeson’s stock options expire?
The stock options granted to the Kodiak Sciences CFO expire on July 14, 2036. If unexercised by that date, they lapse. The grant is structured as a long-term incentive, subject to vesting and his ongoing Continuous Service with the company.
Were Kodiak Sciences (KOD) CFO John A. Borgeson’s options granted under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not affirmatively marked for this transaction. The reported grant is a compensation award under the 2018 Equity Incentive Plan rather than a sale or purchase under a trading plan.